Daily Stock Analysis, CNAT, Conatus Pharmaceuticals Inc, priceseries

Conatus Pharmaceuticals Inc. Daily Stock Analysis
Stock Information
Open
4.59
Close
4.82
High
5.09
Low
4.58
Previous Close
4.59
Daily Price Gain
0.23
YTD High
5.55
YTD High Date
Jan 9, 2017
YTD Low
4.06
YTD Low Date
Jan 30, 2017
YTD Price Change
-0.57
YTD Gain
-10.58%
52 Week High
6.30
52 Week High Date
Dec 27, 2016
52 Week Low
1.45
52 Week Low Date
Nov 4, 2016
52 Week Price Change
2.72
52 Week Gain
129.52%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Mar 18. 2016
1.99
Apr 18. 2016
2.93
20 Trading Days
47.38%
Link
LONG
Nov 9. 2016
1.67
Nov 18. 2016
1.90
7 Trading Days
14.06%
Link
LONG
Dec 19. 2016
1.96
Jan 6. 2017
4.89
12 Trading Days
149.56%
Link
Company Information
Stock Symbol
CNAT
Exchange
NasdaqGM
Company URL
http://www.conatuspharma.com
Company Phone
(858) 376-2600
CEO
Steven J. Mento
Headquarters
California
Business Address
16745 WEST BERNARDO DRIVE, Suite 200, San Diego, CA 92127
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001383701
About

Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States.

Description

Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. Its product candidates include Emricasan, an orally active pan-caspase protease inhibitor that is in Phase II clinical trials for the treatment of liver cirrhosis, acute-on-chronic liver failure, post-orthotopic liver transplant as a result of hepatitis C virus infection with sustained viral response, non-alcoholic steatohepatitis, and nonalcoholic fatty liver disease and raised transaminases, as well as for the treatment of patients with severe alcoholic hepatitis. The company was founded in 2005 and is headquartered in San Diego, California.